Cargando…

LGI1 Encephalitis: Autoimmune Epilepsy or Movement Disorder

Detalles Bibliográficos
Autores principales:	Jagtap, Sujit A., Aurangabadkar, Kaustubh, Joshi, Aniruddha, Chitnis, Sonal, Rathod, Mahendra, Khade, Harshada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666863/ https://www.ncbi.nlm.nih.gov/pubmed/38022447 http://dx.doi.org/10.4103/aian.aian_626_23

Ejemplares similares

LGI1-Antibody Associated Autoimmune Encephalitis Complicated by Primary Polydipsia
por: Yaqoob, Arjimand, et al.
Publicado: (2022)

Striatum Involvement in LGI1 Limbic Encephalitis
por: Plantone, Domenico
Publicado: (2018)

Juvenile Huntington’s disease masquerading as progressive myoclonus epilepsy
por: Thakor, Bina, et al.
Publicado: (2021)

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021)

Characterization of cardiac bradyarrhythmia associated with LGI1-IgG autoimmune encephalitis
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2022)

Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis
por: Sadaghiani, Mohammad S., et al.
Publicado: (2023)

Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis
por: Aboseif, Albert, et al.
Publicado: (2023)

Anti-LGI1 Encephalitis Presented With Prominent Psychosis Without Loss of Consciousness
por: Cho, Ja Hyeon, et al.
Publicado: (2023)

Fire acupuncture for anti-LGI1 antibody autoimmune encephalitis: a case report
por: Liu, Yu, et al.
Publicado: (2023)

Anti-LGI1 encephalitis following COVID-19 vaccination: a case series
por: Asioli, Gian Maria, et al.
Publicado: (2022)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020)

LGI Proteins and Epilepsy in Human and Animals
por: Pakozdy, A., et al.
Publicado: (2015)

Rituximab in Rasmussen’s encephalitis: A single center experience and review of the literature
por: Jagtap, Sujit A., et al.
Publicado: (2022)

The Clinical Value of (18)F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody
por: Liu, Xiao, et al.
Publicado: (2020)

Autoimmune encephalitis with coexistent LGI1 and GABA(B)R1 antibodies: case report
por: Xie, Yi, et al.
Publicado: (2021)

Important Clues for the Diagnosis of Anti-LGI1-Antibody Autoimmune Encephalitis: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Rapidly Progressive Cognitive Impairment with Faciobrachial Dystonic Seizures (FBDS) in Anti-LGI1 Encephalitis
por: Yin, Weifang, et al.
Publicado: (2022)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021)

Rare Case of Anti-LGI1 Limbic Encephalitis with New Onset Epilepsy: A Case Report
por: Kurukumbi, Mohan, et al.
Publicado: (2019)

Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA(B)R encephalitis
por: Shen, Chun‐Hong, et al.
Publicado: (2020)

Hyponatraemia caused by LGI1-associated limbic encephalitis
por: McQuillan, Rory F., et al.
Publicado: (2011)

Clinical features of limbic encephalitis with LGI1 antibody
por: Wang, Meiling, et al.
Publicado: (2017)

Pilomotor Seizures in a Patient With LGI1 Encephalitis
por: Yang, Jinxia, et al.
Publicado: (2020)

Flortaucipir (tau) PET in LGI1 antibody encephalitis
por: Day, Gregory S., et al.
Publicado: (2021)

Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome
por: Kilic, Mehmet Akif, et al.
Publicado: (2021)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis
por: Rissanen, Eero, et al.
Publicado: (2022)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

Intrathecal B-cell activation in LGI1 antibody encephalitis
por: Lehmann-Horn, Klaus, et al.
Publicado: (2020)

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies
por: Qiao, Jianping, et al.
Publicado: (2020)

LGI1 antibody encephalitis: acute treatment comparisons and outcome
por: Rodriguez, Andrew, et al.
Publicado: (2022)

Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis
por: Ludewig, Susann, et al.
Publicado: (2023)

Anti-LGI1 encephalitis with initiating symptom of seizures in children
por: Wang, Yang, et al.
Publicado: (2023)

Neuropsychological and Structural Neuroimaging Outcomes in LGI1-Limbic Encephalitis: A Case Study
por: Joshi, Jarod, et al.
Publicado: (2022)

Similarity of molecular phenotype between known epilepsy gene LGI1 and disease candidate gene LGI2
por: Limviphuvadh, Vachiranee, et al.
Publicado: (2010)

Autoimmune encephalitis
por: Joob, Beuy, et al.
Publicado: (2016)

Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review
por: Li, Xuanting, et al.
Publicado: (2019)

Ofatumumab for the treatment of refractory anti‐LGI1 encephalitis with long‐term poor blood glucose control in type 1 diabetes
por: Chen, Kaili, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpql021n9mefcfkmem2f22tnuf